Drugs / AIDSVAX B/E
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01933685 | Jul 2014 → May 2016 | HIV infectious disease | U.S. Army Medical Research and Development Command | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AIDSVAX B/E | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01933685 ↗ |
| Modality | Vaccine | “The purpose of this study is to define the immune responses induced by a HIV vaccine, AIDSVAX B/E.” NCT01933685 ↗ |